Cargando…

Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study

BACKGROUND: Recognising the importance of clinical outcomes assessments (COAs), the Response Assessment in Neuro-Oncology-Patient Reported Outcome (RANO-PRO) Working Group recommended inclusion of core symptoms and functions in clinical care or research for malignant glioma patients. This study eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vera, Elizabeth, Christ, Alexa, Grajkowska, Ewa, Briceno, Nicole, Choi, Anna, Crandon, Sonja K., Wall, Kathleen, Lindsley, Matthew, Leeper, Heather E., Levine, Jason, Reyes, Jennifer, Acquaye, Alvina A., King, Amanda L., Jammula, Varna, Roche, Kayla, Rogers, James L., Timmer, Michael, Boris, Lisa, Lollo, Nicole, Panzer, Marissa, Polskin, Lily, Pillai, Tina, Burton, Eric, Penas-Prado, Marta, Theeler, Brett, Gilbert, Mark R., Armstrong, Terri S., Mendoza, Tito R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661442/ https://www.ncbi.nlm.nih.gov/pubmed/36386035 http://dx.doi.org/10.1016/j.eclinm.2022.101718

Ejemplares similares

QOLP-19. FINANCIAL TOXICITY AND DISTRESS DURING THE COVID-19 PANDEMIC IN PEOPLE LIVING WITH PRIMARY BRAIN TUMORS
por: Leeper, Heather, et al.
Publicado: (2021)

NCOG-23. PATIENT-REPORTED SYMPTOM BURDEN AND INTERFERENCE: A COMPARISON BETWEEN COVID-19 PANDEMIC YEAR AND NORMATIVE DATA IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Pillai, Valentina, et al.
Publicado: (2021)

QOLP-37. MOOD DISTURBANCE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS DURING THE COVID-19 PANDEMIC
por: Polskin, Lily, et al.
Publicado: (2021)

The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments
por: Jammula, Varna, et al.
Publicado: (2022)

Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial
por: King, Amanda L., et al.
Publicado: (2023)

Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial
por: King, Amanda L., et al.
Publicado: (2023)

Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1-altered CNS tumors: A case report and systematic literature review
por: Frederico, Stephen C., et al.
Publicado: (2023)

Effects of Cognitive Reserve on Cognition in Individuals With Central Nervous System Disease
por: Jammula, Varna R., et al.
Publicado: (2021)

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy
por: Chen, Xin, et al.
Publicado: (2021)

Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2023)

CLRM-07 RANO 2.0: PROPOSAL FOR AN UPDATE TO THE RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA FOR HIGH- AND LOW-GRADE GLIOMAS IN ADULTS
por: Wen, Patrick, et al.
Publicado: (2023)

The prevalence of altered body image in patients with primary brain tumors: an understudied population
por: Rowe, Lindsay, et al.
Publicado: (2020)

The LUMIERE dataset: Longitudinal Glioblastoma MRI with expert RANO evaluation
por: Suter, Yannick, et al.
Publicado: (2022)

Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section
por: Lynes, John, et al.
Publicado: (2020)

MLTI-13. RESPONSE ASSESSMENT OF MELANOMA BRAIN METASTASES TREATED BY STEREOTACTIC RADIOTHERAPY OR IMMUNOTHERAPY OR BOTH: A COMPARISON OF RECIST 1.1, RANO AND iRANO CRITERIA
por: Le Rhun, Emilie, et al.
Publicado: (2019)

Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation
por: Linhares, Paulo, et al.
Publicado: (2013)

Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas
por: Raman, Fabio, et al.
Publicado: (2023)

Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial
por: King, Amanda L., et al.
Publicado: (2023)

U(rano)topia: spectral skies and rainbow holograms for silica aerogel artworks
por: Michaloudis, Ioannis, et al.
Publicado: (2022)

Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice
por: Chukwueke, Ugonma N, et al.
Publicado: (2019)

Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial
por: King, Amanda L., et al.
Publicado: (2023)

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
por: Boire, Adrienne, et al.
Publicado: (2019)

Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough?
por: Imber, Brandon S, et al.
Publicado: (2019)

Response Assessment in Brain Metastases Managed by Stereotactic Radiosurgery: A Reappraisal of the RANO-BM Criteria
por: Douri, Keiss, et al.
Publicado: (2023)

Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment
por: Al Feghali, Karine A, et al.
Publicado: (2021)

INNV-27. AN INNOVATIVE VIRTUAL MULTI-INSTITUTIONAL, MULTIDISCIPLINARY NEURO-ONCOLOGY TUMOR BOARD: THE NIH-NOB EXPERIENCE DURING THE COVID-19 PANDEMIC
por: Rogers, James, et al.
Publicado: (2021)

Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey
por: Rogers, James L, et al.
Publicado: (2020)

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2022)

Autism and mental illness in children and young people require standardised approaches for assessment and treatment
por: Lai, Alvina G., et al.
Publicado: (2022)

Rapa Nui (Easter Island) Rano Raraku crater lake basin: Geochemical characterization and implications for the Ahu-Moai Period
por: Argiriadis, E., et al.
Publicado: (2021)

Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews
por: Acquaye, Alvina A., et al.
Publicado: (2019)

NS-HGlio: A generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinics
por: Abayazeed, Aly H, et al.
Publicado: (2022)

Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study
por: Bjorland, Line Sagerup, et al.
Publicado: (2023)

Standardisation and international adoption of defined approaches for skin sensitisation
por: Casati, Silvia, et al.
Publicado: (2022)

Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas
por: Moon, Hye Hyeon, et al.
Publicado: (2021)

STANDARDISATION OF KARPURASAVA
por: Alam, Muzaffer, et al.
Publicado: (1994)

STANDARDISATION OF DIKAMALI
por: Anandakumar, A., et al.
Publicado: (1984)

STANDARDISATION OF ELADICHOORNAM
por: Thankamma, A., et al.
Publicado: (1998)

The Standardisation of Sera
Publicado: (1921)

TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_977d1er5d0v7v3eo4cchs9vaem